These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24836395)

  • 1. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.
    Valent P; Escribano L; Broesby-Olsen S; Hartmann K; Grattan C; Brockow K; Niedoszytko M; Nedoszytko B; Oude Elberink JN; Kristensen T; Butterfield JH; Triggiani M; Alvarez-Twose I; Reiter A; Sperr WR; Sotlar K; Yavuz S; Kluin-Nelemans HC; Hermine O; Radia D; van Doormaal JJ; Gotlib J; Orfao A; Siebenhaar F; Schwartz LB; Castells M; Maurer M; Horny HP; Akin C; Metcalfe DD; Arock M;
    Allergy; 2014 Oct; 69(10):1267-74. PubMed ID: 24836395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).
    Valent P; Aberer E; Beham-Schmid C; Fellinger C; Fuchs W; Gleixner KV; Greul R; Hadzijusufovic E; Hoermann G; Sperr WR; Wimazal F; Wöhrl S; Zahel B; Pehamberger H
    Am J Blood Res; 2013; 3(2):174-80. PubMed ID: 23675567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis.
    Kristensen T; Vestergaard H; Bindslev-Jensen C; Mortz CG; Kjaer HF; Ollert M; Møller MB; Broesby-Olsen S;
    Allergy; 2017 Nov; 72(11):1737-1743. PubMed ID: 28432683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
    Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
    Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.
    Gülen T; Hägglund H; Dahlén B; Nilsson G
    J Intern Med; 2016 Mar; 279(3):211-28. PubMed ID: 26347286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis.
    Kristensen T; Vestergaard H; Bindslev-Jensen C; Møller MB; Broesby-Olsen S;
    Am J Hematol; 2014 May; 89(5):493-8. PubMed ID: 24443360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.
    Valent P; Akin C; Bonadonna P; Hartmann K; Brockow K; Niedoszytko M; Nedoszytko B; Siebenhaar F; Sperr WR; Oude Elberink JNG; Butterfield JH; Alvarez-Twose I; Sotlar K; Reiter A; Kluin-Nelemans HC; Hermine O; Gotlib J; Broesby-Olsen S; Orfao A; Horny HP; Triggiani M; Arock M; Schwartz LB; Metcalfe DD
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1125-1133.e1. PubMed ID: 30737190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastocytosis - an update.
    Amon U; Hartmann K; Horny HP; Nowak A
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
    Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
    J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
    Theoharides TC; Boucher W; Spear K
    Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mastocytosis, classification, biological diagnosis and therapy].
    Arock M
    Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.
    De Matteis G; Zanotti R; Colarossi S; De Benedittis C; Garcia-Montero A; Bonifacio M; Sartori M; Aprili F; Caruso B; Paviati E; Carli G; Perbellini O; Zamò A; Bonadonna P; Pizzolo G; Guidi G; Martinelli G; Soverini S
    Leuk Res; 2015 Mar; 39(3):273-8. PubMed ID: 25582384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.
    Teodosio C; García-Montero AC; Jara-Acevedo M; Alvarez-Twose I; Sánchez-Muñoz L; Almeida J; Morgado JM; Matito A; Escribano L; Orfao A
    Leukemia; 2012 May; 26(5):951-8. PubMed ID: 22051531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.